GlassScriptPhysician profile
Jason Paul Ludlow
NPI 1588051791
$7,845.35
in general payments reported to CMS, 2019-2025
18 companies · $744 in 2025
The $744 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $365 · 2021: $190 · 2022: $155 · 2023: $5,782 · 2024: $387 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,378 · Food and Beverage: $1,535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,378.06 |
| Food and Beverage | $1,534.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $6,518.06 | 2019-2025 | Clareon, Rocklatan, Hydrus Microstent |
| Abbvie INC. | $329.96 | 2023-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $329.67 | 2020-2025 | Veritas Vision System, Tecnis Iol |
| Sight Sciences, INC. | $133.07 | 2020-2023 | Omni Surgical System |
| Amgen INC. | $114.22 | 2022-2025 | Otezla, Tepezza |
| Mallinckrodt Hospital Products INC. | $101.33 | 2021-2025 | Acthar |
| Ivantis, INC | $53.11 | 2021 | |
| Harrow Eye, LLC | $51.03 | 2024-2025 | Iheezo, Vevye |
| Oyster Point Pharma, INC. | $37.25 | 2022-2023 | Tyrvaya |
| Carl Zeiss Meditec USA, INC. | $26.18 | 2022 | |
| Glaukos Corporation | $22.94 | 2025 | Idosetr |
| Bausch & Lomb Americas INC. | $22.91 | 2025 | Miebo |
| Rxsight INC | $21.90 | 2022 | |
| Beaver-Visitec International, INC. | $21.24 | 2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $16.87 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $16.63 | 2023 | |
| Allergan, INC. | $15.34 | 2020 | |
| Thea Pharma INC. | $13.64 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Ludlow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.